Loading...
Quality of life in cutaneous t-cell lymphoma patients treated with the Anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from MAVORIC.
Huen, A Porcu, P Hudgens, S Quaglino, P Floden, L Tsianakas, A Leoni, M Dale, S Duvic, M
Huen, A
Porcu, P
Hudgens, S
Quaglino, P
Floden, L
Tsianakas, A
Leoni, M
Dale, S
Duvic, M
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Quality of life in cutaneous t-cell lymphoma patients treated with the Anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from MAVORIC. 2018, 18:S289 Clin Lymphoma Myeloma Leuk